Efficient Synthesis of Ganglioside GM2 for Use in Cancer Vaccines
β Scribed by Julio C. Castro-Palomino; Dr. Gerd Ritter; Sheila R. Fortunato; Stefan Reinhardt; Dr. Lloyd J. Old; Prof. Dr. Richard R. Schmidt
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 590 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0044-8249
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
An efficiently stereocontrolled total synthesis of GM3 alpha-D-Neup5Ac-(2----3)-beta-D-Galp-(1----4)-beta-D-Glcp-(1----1) -Cer was achieved by employing both methyl 5-acetamido-4,7,8,9-tetra-O-benzyl-2-bromo-2,3,5-trideoxy-3- phenylthio-D-erythro-beta-L-gluco-2-nonulopyranosonate for the key sialyla
## Abstract __Two metabolically engineered__ Escherichia coli __strains have been constructed to produce the carbohydrate moieties of gangliosides GM2 (GalNAc__Ξ²__β4(NeuAc__Ξ±__β3)Gal__Ξ²__β4Glc; Gal=galactose, Glc=glucose, Ac=acetyl) and GM1 (Gal__Ξ²__β3GalNAc__Ξ²__β4(NeuAc__Ξ±__β3)Gal__Ξ²__β4Glc. The G